These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30138198)

  • 41. Thrombopoietin-receptor agonists for primary immune thrombocytopenia.
    Imbach P; Crowther M
    N Engl J Med; 2011 Aug; 365(8):734-41. PubMed ID: 21864167
    [No Abstract]   [Full Text] [Related]  

  • 42. A single center experience with romiplostim for the management of chemotherapy-induced thrombocytopenia.
    Miao J; Leblebjian H; Scullion B; Parnes A
    Am J Hematol; 2018 Aug; 93(4):E86-E88. PubMed ID: 29274130
    [No Abstract]   [Full Text] [Related]  

  • 43. Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome.
    Gauchan D; Shaaban H; Gedeon D; Maroules M
    Ann Hematol; 2014 Oct; 93(10):1777-8. PubMed ID: 24554304
    [No Abstract]   [Full Text] [Related]  

  • 44. Structure-activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor.
    Antipas AS; Blumberg LC; Brissette WH; Brown MF; Casavant JM; Doty JL; Driscoll J; Harris TM; Jones CS; McCurdy SP; McElroy E; Mitton-Fry M; Munchhof MJ; Reim DA; Reiter LA; Ripp SL; Shavnya A; Smeets MI; Trevena KA
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4069-72. PubMed ID: 20558059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Romiplostim.
    Kuter DJ
    Cancer Treat Res; 2011; 157():267-88. PubMed ID: 21052962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eltrombopag fails to improve severe thrombocytopenia in late-stage dyskeratosis congenita and diamond-blackfan-anaemia.
    Trautmann K; Jakob C; von Grünhagen U; Schleyer E; Brümmendorf TH; Siegert G; Ehninger G; Platzbecker U
    Thromb Haemost; 2012 Aug; 108(2):397-8. PubMed ID: 22739569
    [No Abstract]   [Full Text] [Related]  

  • 47. Development of a new knock-in mouse model and evaluation of pharmacological activities of lusutrombopag, a novel, nonpeptidyl small-molecule agonist of the human thrombopoietin receptor c-Mpl.
    Yoshida H; Yamada H; Nogami W; Dohi K; Kurino-Yamada T; Sugiyama K; Takahashi K; Gahara Y; Kitaura M; Hasegawa M; Oshima I; Kuwabara K
    Exp Hematol; 2018 Mar; 59():30-39.e2. PubMed ID: 29274361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eltrombopag in thrombocytopenia.
    Lawson A
    N Engl J Med; 2008 Mar; 358(10):1072; author reply 1072-3. PubMed ID: 18322290
    [No Abstract]   [Full Text] [Related]  

  • 49. A case of acute stent thrombosis during treatment with the thrombopoietin receptor agonist peptide--romiplostim.
    Rayoo R; Sharma N; van Gaal WJ
    Heart Lung Circ; 2012 Mar; 21(3):182-4. PubMed ID: 21963397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP).
    Gernsheimer TB; George JN; Aledort LM; Tarantino MD; Sunkara U; Matthew Guo D; Nichol JL
    J Thromb Haemost; 2010 Jun; 8(6):1372-82. PubMed ID: 20230419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eltrombopag: a novel oral thrombopoietin receptor agonist.
    Corman SL; Mohammad RA
    Ann Pharmacother; 2010 Jun; 44(6):1072-9. PubMed ID: 20460556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopenia.
    Berthelot-Richer M; Boilard B; Morin A; Bolduc B; Beauregard P; Kotb R
    Transfusion; 2012 Apr; 52(4):739-41. PubMed ID: 22082044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two cases of thrombosis in patients with antiphospholipid antibodies during treatment of immune thrombocytopenia with romiplostim, a thrombopoietin receptor agonist.
    LaMoreaux B; Barbar-Smiley F; Ardoin S; Madhoun H
    Semin Arthritis Rheum; 2016 Feb; 45(4):e10-2. PubMed ID: 26329147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune thrombocytopenia and anticoagulation: the role of romiplostim in the early treatment.
    Cantoni N; Heizmann M; Bargetzi M
    Br J Haematol; 2012 Jun; 157(5):639-41. PubMed ID: 22329466
    [No Abstract]   [Full Text] [Related]  

  • 55. Review article: pharmacological approaches for the treatment of thrombocytopenia in patients with chronic liver disease and hepatitis C infection.
    Afdhal NH; McHutchison JG
    Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():29-39. PubMed ID: 17958517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New Drugs 2019, part 4.
    Hussar DA
    Nursing; 2019 Nov; 49(11):34-43. PubMed ID: 31651773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial.
    Oliva EN; Alati C; Santini V; Poloni A; Molteni A; Niscola P; Salvi F; Sanpaolo G; Balleari E; Germing U; Fenaux P; Stamatoullas A; Palumbo GA; Salutari P; Impera S; Avanzini P; Cortelezzi A; Liberati AM; Carluccio P; Buccisano F; Voso MT; Mancini S; Kulasekararaj A; Morabito F; Bocchia M; Cufari P; Spiriti MA; Santacaterina I; D'Errigo MG; Bova I; Zini G; Latagliata R
    Lancet Haematol; 2017 Mar; 4(3):e127-e136. PubMed ID: 28162984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Eltrombopag for treatment of thrombocytopenia-associated disorders.
    Merli P; Strocchio L; Vinti L; Palumbo G; Locatelli F
    Expert Opin Pharmacother; 2015; 16(14):2243-56. PubMed ID: 26364898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Avatrombopag.
    Bussel JB
    Br J Haematol; 2018 Nov; 183(3):342-343. PubMed ID: 30351482
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy of Repeated Lusutrombopag Administration for Thrombocytopenia in a Patient Scheduled for Invasive Hepatocellular Carcinoma Treatment.
    Sato S; Miyake T; Kataoka M; Isoda K; Yazaki T; Tobita H; Ishimura N; Kinoshita Y
    Intern Med; 2017 Nov; 56(21):2887-2890. PubMed ID: 28943563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.